The role of RalA in biology and therapy of ovarian cancer.

Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.

Camilynn I. Brannan, Archibald S. Perkins, Kristine S. Vogel et al. · Genes & Development · 1994 · 641 citations · Full text

Neurofibromatosis Type-1 Gene, Nf1 Disease, Developmental Biology +15

Development of a syngeneic mouse model for events related to ovarian cancer

Katherine F. Roby, Christopher Taylor, J. P. Sweetwood et al. · Carcinogenesis · 2000 · 588 citations · Full text

Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase

Mark Manfredi, Jeffrey Ecsedy, Kristan Meetze et al. · Proceedings of the National Academy of Sciences · 2007 · 413 citations · Full text

Tumor Biology, Active Small-molecule Inhibitor, Antitumor Activity +15

CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells

M-Q Gao, Y-P Choi, Suki Kang et al. · Oncogene · 2010 · 390 citations · Full text

Lineage Plasticity, Developmental Biology, Cell Specialization +12

RalB GTPase-Mediated Activation of the IκB Family Kinase TBK1 Couples Innate Immune Signaling to Tumor Cell Survival

Yuchen Chien, Sungchan Kim, Ron Bumeister et al. · Cell · 2006 · 365 citations · Full text

Tumor Biology, Signal Transduction, Signaling Pathway +12